Breaking News, Collaborations & Alliances

Trenchant BioSystems, Invetech Partner to Advance Trenchant’s AutoCell Platform

Aim to develop a fully automated CGT manufacturing solution designed to materially reduce cost by up to 80% and manufacturing time by up to 95%.

Author Image

By: Charlie Sternberg

Associate Editor

After signing a nonbinding letter of intent in February, Trenchant BioSystems Inc., a CGT manufacturing platform developer, and Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, have entered into a strategic alliance focused on the continued development of Trenchant’s fully automated AutoCell Platform, intended for future commercialization. “Current cell and gene therapy manufacturing practices are ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters